In the Journals

Wet AMD gene therapy well tolerated through 3 years

August 23, 2019
Patients with wet age-related macular degeneration who responded well to rAAV.sFLT-1 subretinal gene therapy at 1 year maintained that response…

ONL raises $3 million in financing to advance Fas inhibitor study

August 23, 2019
ONL Therapeutics will begin a first-in-human study of its Fas inhibitor for retinal diseases following the completion of $3 million in convertible…

Iconic, Novartis sign ophthalmology option agreement

August 23, 2019
Iconic Therapeutics has signed an agreement with Novartis that will give Novartis an option on Iconic’s ophthalmology program, according to a…

Adverum posts net loss in second quarter

August 23, 2019
Adverum Biotechnologies reported a second quarter net loss of $15 million, or $0.23 per share, compared with a net loss of $18.8 million, or $0.30…
In the Journals

Vehicle pollution may increase AMD risk

August 22, 2019
High rates of exposure to traffic-related air pollution may increase the risk for age-related macular degeneration. Nearly 40,000 Taiwanese residents…

Ahmed ClearPath glaucoma drainage device launches

August 22, 2019
The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States, New World Medical announced in a press release…

Mixed phase 2a results reported for Oxurion’s anti-PlGF combined with anti-VEGF

August 22, 2019
THR-317, a humanized antibody against placental growth factor, combined with ranibizumab showed no improvement in mean best corrected visual acuity…

Alcon posts $390 million quarterly net loss

August 22, 2019
Alcon reported a net loss of $390 million, or $0.80 per share, in 2019’s second quarter compared with a net income of $15 million, or $0.03 per…
In the Journals

Once-daily netarsudil noninferior to twice-daily timolol in phase 3 study

August 21, 2019
Once-daily netarsudil was noninferior to twice-daily timolol for IOP-lowering efficacy in patients with open-angle glaucoma or ocular hypertension…

Graybug Vision completes Series C financing

August 21, 2019
Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its…
Feature

One health system’s experience relevant to looming price transparency rule

August 21, 2019
The Trump administration’s ongoing effort to lower health care costs and increase transparency resumes later this summer when HHS is expected…

Omeros posts lower net loss in second quarter

August 21, 2019
Omeros reported a second quarter net loss of $14.5 million, or $0.29 per share, compared with a net loss of $33.7 million, or $0.70 per share, in…
Blog

BLOG: Disrupting your surgical referrals

August 20, 2019
One concern shared with me by eye surgeons is what would happen to surgical volume if referral sources are pulled away. That threat may still be far…

Aerie begins trial of sustained release drug for retinal disease

August 20, 2019
Aerie Pharmaceuticals has initiated a clinical trial of AR-13503, a sustained release implant, for treatment of neovascular age-related macular…
In the Journals

Sutureless dacryocystorhinostomy closure scars less than subcuticular technique

August 20, 2019
A sutureless wound closure technique led to less scarring and better cosmesis than subcuticular technique in external dacryocystorhinostomy…

Second Sight’s second quarter net loss increases

August 20, 2019
Second Sight Medical Products reported a net loss of $8.4 million, or $0.07 per share, for the second quarter of 2019 compared with a net loss of $8…
Blog

BLOG: Why do we treat patients like camels?

August 19, 2019
There’s an old expression, “Nobody cares what his camel thinks till it dies in the middle of the Sahara.” Uncomplaining, a camel is…

Wyanoke Group announces Healio rebranding

August 19, 2019
In an effort to improve the user experience for its health provider audiences, the Wyanoke Group is rebranding its live event, digital and publishing…
In the Journals

Tumor reduction sustained with fractionated stereotactic radiotherapy

August 19, 2019
Lesion reduction was sustained and visual function improved in eyes treated with fractionated stereotactic radiotherapy for cavernous venous…
Point/Counter

Would you recommend generic drugs to a family member?

Ocular Surgery News U.S. Edition, August 25, 2019
Would I prescribe generics to my family? Yes. I believe that all physicians treat all of their patients like family. I do as well. I prescribe…